Search results for " stroke"

showing 10 items of 328 documents

Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis.

2008

Abstract Introduction Accumulating evidence suggests that inflammation plays an important role in the development of acute cerebrovascular disease. The aim of this study is to evaluate the predictive value of a series of candidate serum immuno-inflammatory and thrombotic/fibrinolitic molecules towards diagnosis of acute ischemic stroke. Materials and methods We enrolled 120 consecutive patients with a diagnosis of acute ischemic stroke and 123 consecutive hospitalized control patients without a diagnosis of acute ischemic stroke. We evaluated plasma levels of IL-1β, TNF-β, IL-6 and IL-10, E-selectin, P-selectin, sICAM-1 and sVCAM-1 as markers of immuno-inflammatory activation, vWF plasma le…

Malemedicine.medical_specialtyPathologySettore MED/09 - Medicina Internamedicine.medical_treatmentImmuno-inflammatory thrombotic/fibrinolytic acute ischemic strokeBrain IschemiaBrain ischemiaPredictive Value of TestsRisk FactorsInternal medicineFibrinolysisstroke inflammation predictive markersmedicineHumansEndothelial dysfunctionStrokeAgedAged 80 and overInflammationVascular diseasebusiness.industryCerebral infarctionFibrinolysisBrainThrombosisMiddle Agedmedicine.diseaseThrombosisStrokeROC CurveImmune SystemPredictive value of testsCardiologyFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

Fetuin-A and CD40L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory vari…

2009

Abstract Introduction Accumulating evidence suggests that inflammation plays an important role in the acute phase of ischemic stroke. CD40 L is a well recognized atherosclerotic inflammatory marker, whereas recent evidence suggests a pro-inflammatory role of Fetuin-A. To analyze the role of an inflammatory marker such as CD40 L and of a candidate pro-inflammatory marker such as Fetuin-A in acute stroke we evaluated their serum levels in subjects with acute ischemic stroke and their possible association with other laboratory and clinical variables. Materials and methods We enrolled 107 consecutive patients with a diagnosis of acute ischemic stroke admitted to the Internal Medicine Department…

Malemedicine.medical_specialtyPathologyalpha-2-HS-GlycoproteinCD40 LigandGastroenterologyBrain IschemiaCentral nervous system diseaseBrain ischemiaInternal medicineDiabetes mellitusWhite blood cellmedicineHumansStrokeAgedAged 80 and overbusiness.industryCerebral infarctionVascular diseaseBlood ProteinsMiddle Agedmedicine.diseaseStrokemedicine.anatomical_structureAcute DiseaseFemaleCardiology and Cardiovascular MedicinebusinessFetuin-A CD40L strokealpha-2-HS-glycoprotein
researchProduct

Time Trends in Hospital-Referred Stroke and Transient Ischemic Attack: Results of a 7-Year Nationwide Survey in France

2010

<i>Background:</i> Nationwide evaluations of the burden of stroke are scarce. We aimed to evaluate trends in stroke and transient ischemic attack (TIA) hospitalization, in-hospital case fatality rates (CFRs) and mortality rates in France during 2000–2006. <i>Methods:</i> Hospitalizations for stroke and TIA were determined from National Hospital Discharge Diagnosis Records that used the International Classification of Disease, 10th revision, codes I60, I61, I63, I64, G45, G46. CFRs and mortality rates were estimated from the national death certificates database. <i>Results:</i> The total number of stays for stroke increased between 2000 and 2006 (88,371 vs…

Malemedicine.medical_specialtyPediatrics030204 cardiovascular system & hematologyStroke mortalityNationwide survey03 medical and health sciences0302 clinical medicineHealth care policyEpidemiologymedicineHumansOrganized stroke careLongitudinal Studiescardiovascular diseasesTransient ischemic attackStrokeAgedRetrospective StudiesAged 80 and overHospital stayIn hospital mortalityStroke epidemiologyTime trendsbusiness.industryRetrospective cohort studyLength of Staymedicine.diseaseHealth Surveysnervous system diseases3. Good healthHospitalizationSurvival RateStrokeIn-hospital mortalityNeurologyIschemic Attack TransientTissue Plasminogen ActivatorIncidence and mortality ratesFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessHospital stay030217 neurology & neurosurgery
researchProduct

Impact of the Ageing Population on the Burden of Stroke: The Dijon Stroke Registry.

2018

<b><i>Background:</i></b> We aimed to evaluate the impact of the ageing population on temporal trends in burden of stroke and to provide projections for the coming years. <b><i>Methods:</i></b> Stroke cases (ischemic strokes, spontaneous intracerebral hemorrhages, or undetermined strokes) were prospectively identified between 1987 and 2015 in Dijon, France, using a population-based registry. Age-standardized incidence rates of first-ever and recurrent stroke were calculated, and their temporal trends were assessed using age- and sex-adjusted annual incidence rate ratios (RR). <b><i>Results:</i></b> The population of Dij…

Malemedicine.medical_specialtyPediatricsPopulation ageingStroke registryAgingEpidemiologyPopulationRecurrent strokeRisk FactorsEpidemiologyCase fatality ratemedicineHumanscardiovascular diseasesRegistrieseducationStrokeAgedAged 80 and overeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceAge FactorsMiddle Agedmedicine.diseaseStrokeFemaleNeurology (clinical)FrancebusinessNeuroepidemiology
researchProduct

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

2014

BACKGROUND AND OBJECTIVES:: It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these…

Malemedicine.medical_specialtyPhysiologyHypercholesterolemiaLow density lipoprotein cholesterolBlood Pressurelaw.inventionCognitionRandomized controlled triallawRecurrenceInternal medicineblood pressure cognitive decline low-density lipoprotein cholesterol primary prevention secondary prevention strokeInternal MedicineSecondary PreventionMedicineHumansCognitive declineStrokeBeneficial effectsRandomized Controlled Trials as TopicSecondary preventionbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARECholesterol LDLmedicine.diseasePrimary PreventionStrokeBlood pressureCholesterolCardiologyPhysical therapylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessStroke incidenceCognition Disordersblood pressure; cognitive decline; low-density lipoprotein cholesterol; primary prevention; secondary prevention; strokeJournal of hypertension
researchProduct

Improvement of the circulatory function partially accounts for the neuroprotective action of the phytoestrogen genistein in experimental ischemic str…

2012

Abstract We tested the hypothesis that the phytoestrogen genistein protects the brain against ischemic stroke by improving the circulatory function in terms of reduced production of thromboxane A2 and leukocyte–platelet aggregates, and of preserved vascular reactivity. Ischemia-reperfusion (90 min-3 days, intraluminal filament) was induced in male Wistar rats, and functional score and cerebral infarct volume were the end points examined. Genistein (10 mg/kg/day) or vehicle (β-cyclodextrin) was administered at 30 min after ischemia or sham-operation. Production of thromboxane A2 and leukocyte–platelet aggregates, as well as reactivity of carotid artery to U-46619 (thromboxane A2 analogue) an…

Malemedicine.medical_specialtyPlatelet AggregationIschemiaGenisteinPhytoestrogensNeuroprotectionBrain IschemiaThromboxane A2Thromboxane A2chemistry.chemical_compoundInternal medicinemedicineAnimalsPlateletRats WistarStrokePharmacologyChemistrymedicine.diseaseGenisteinRatsStrokeNeuroprotective AgentsEndocrinologyCirculatory systemIschemic strokeEuropean Journal of Pharmacology
researchProduct

Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke: The Dijon Stroke Registry.

2020

Background and Purpose— The ongoing ageing population is associated with an increasing number of patients with stroke who have preexisting cognitive impairment. This study aimed to evaluate clinical severity in patients with ischemic stroke according to prestroke cognitive status. Methods— Patients with ischemic stroke were prospectively identified among residents of Dijon, France using a population-based registry (2013–2017). Prestroke cognitive status (no impairment, mild cognitive impairment [MCI], or dementia) was recorded, and severity at stroke onset was measured using the National Institutes of Health Stroke Scale (NIHSS) score. Association between prestroke cognitive status and sev…

Malemedicine.medical_specialtyPopulationSeverity of Illness IndexInterquartile rangeInternal medicineEpidemiologymedicineDementiaHumansCognitive DysfunctionProspective StudiesRegistrieseducationCognitive impairmentStrokeAgedAdvanced and Specialized NursingAged 80 and overeducation.field_of_studybusiness.industryOdds ratiomedicine.diseaseStrokeIschemic strokeFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessStroke
researchProduct

MRI patient selection for endovascular thrombectomy in acute ischemic stroke: correlation between pretreatment diffusion weighted imaging and outcome…

2018

Introduction: Eligibility for endovascular treatment (EVT) in patients with acute ischemic stroke (AIS) depends, amongst other factors, on CT- or MR-based scores. The aim of this study was to investigate the role of Alberta Stroke Program Early CT score based on diffusion weighted imaging (MR-ASPECT) in the assessment of brain damage pre-EVT, patient selection for EVT and outcome. Materials and methods: We included in this study patients with National Institute of Health stroke score (NIHSS) at admission ≥ 8, MR-ASPECT ≥ 5 and anterior AIS, who were treated with EVT in our hospital. All patients were clinically evaluated at admission, post-EVT, discharge and at 3-month follow-up. We used MR…

Malemedicine.medical_specialtyRadiology Nuclear Medicine and Imagingmedicine.medical_treatmentDiffusion weighted imaging; Magnetic resonance; Revascularization; Stroke; Aged; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Endovascular Procedures; Female; Humans; Male; Stroke; Thrombectomy; Tomography X-Ray Computed; Treatment Outcome; Patient Selection; Radiology Nuclear Medicine and ImagingRevascularizationBrain Ischemia03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineStrokeNeuroradiologyAgedThrombectomymedicine.diagnostic_testbusiness.industryCerebral infarctionPatient SelectionRevascularizationEndovascular ProceduresInterventional radiologyMagnetic resonance imagingDiffusion weighted imagingGeneral MedicineThrombolysismedicine.diseaseCollateral circulationStrokeDiffusion Magnetic Resonance ImagingTreatment OutcomeMagnetic resonanceFemaleRadiologybusinessTomography X-Ray Computed030217 neurology & neurosurgery
researchProduct

Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke.

2010

Abstract No study has yet evaluated the relationship between arterial stiffness indexes and immuno-inflammatory pathway in patients with an acute cardiovascular or cerebrovascular event. The aim of our study was to evaluate in patients with acute ischemic stroke the relationship between immune-inflammatory markers and arterial stiffness indexes. Methods 107 subjects with acute ischemic stroke and 107 controls without stroke. We evaluated plasma levels of C-reactive protein (CRP), interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaEmbolismTissue plasminogen activatorVon Willebrand factorIschemiaInternal medicinevon Willebrand FactormedicineHumanscardiovascular diseasesStrokePulse wave velocityAgedAged 80 and overInflammationbiologybusiness.industryCerebral infarctionMiddle Agedmedicine.diseaseAtherosclerosisischemic stroke arterial stiffnessSurgeryStrokeCarotid ArteriesImmune SystemAcute Diseasecardiovascular systemArterial stiffnessCardiologybiology.proteinCytokinesAortic stiffnessFemaleCardiology and Cardiovascular MedicinebusinessPlasminogen activatorcirculatory and respiratory physiologymedicine.drugAtherosclerosis
researchProduct

Neurological complications of Anderson-Fabry disease

2012

Characteristic clinical manifestations of AFD such as acroparesthesias, angiokeratoma, corneal opacity, hypo/ and anhidrosis, gastrointestinal symptoms, renal and cardiac dysfunctions can occur in male and female patients, although heterozygous females with AFD usually seems to be less severely affected. The most prominent CNS manifestations consist of cerebrovascular events such as transient ischaemic attacks (TIAs) and (recurrent) strokes . For the most part, CNS complications in AFD have been attributed to cerebral vasculopathy, including anatomical abnormalities. The natural history of Fabry patients includes transitory cerebral ischaemia and strokes, even in very young persons of both …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPopulationTransient ischaemic attacksPulvinarSeverity of Illness IndexInternal medicineDrug DiscoverymedicinePrevalenceHumanseducationStrokeDepression (differential diagnoses)Pharmacologyeducation.field_of_studySex Characteristicsbusiness.industryAge Factorsmedicine.diseaseFabry diseaseHyperintensitySurgeryAngiokeratomaStrokePeripheral neuropathyIschemic Attack TransientCerebrovascular Circulationalpha-GalactosidaseCardiologyFabry DiseaseFemaleAnderson-Fabry disease Neurological strokebusiness
researchProduct